Found 11 matching trials
Huachansu & Gemcitabine in Pancreatic Cancer PHASE2 This protocol is part of a larger grant funded by the NCI to create an inte...
Show More Location
Cancer Hospital Fudan University
Learn More & Join Trial
Clinical Trial of Cinobufacini Injection Combined With Oxaliplatin Regimen on Gastrointestine Carcinoma PHASE4 The clinical trail of Cinobufacini injection combined with Oxaliplatin regi...
Show More Location
The First Affiliated Hospital of Dalian Medical University
Learn More & Join Trial
Role of Huachansu in Treating Hepatocellular Carcinoma and the Correlation With Na+/K+-ATPase PHASE2 Primary Outcome Measures:
\- To compare the progression free survival(PFS)...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver Cancer PHASE4 The clinical trail of Cinobufacini combined with TACE on primary liver canc...
Show More Location
The First Affiliated Hospital of Dalian Medical University
Learn More & Join Trial
Cinobufacini Tablets Combined With Chemotherapeutic Protocol in Treatment of Diffuse Large B Cell Lymphoma PHASE2 Diffuse large B cell lymphoma (DLBCL), as the most common subtype non-Hodgk...
Show More Location
Cancer Hospital Affiliated to Xinjiang Medical University
Learn More & Join Trial
The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects PHASE3 The enriched HBV-related advanced HCC patient population (composite biomark...
Show More Location
Anhui Provincial Hospital
Learn More & Join Trial
Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP) PHASE3 A study to evaluate the efficacy and safety of icaritin versus huachansu in...
Show More Location
The Second Affiliated Hospital of Nanchang University
Learn More & Join Trial
Study of Hepatoma Treated by Perfusing Cinobufacin Through Hepatic Artery Combining Embolotherapy PHASE2 Cinobufacini has the effects of anticancer, improving the liver function, e...
Show More Location
Department of TCM, Changhai Hospital of Shanghai
Learn More & Join Trial
A Tolerance Trial of Cinobufacini Injection Intraperitoneal Perfusion on Digestive System Cancer With Ascites PHASE1 To evaluate the tolerance and safety of cinobufacini injection intraperiton...
Show More Location
Oncology dept; Dongfang Hospital Affiliated to Beijing University of Chinese Medicine
Learn More & Join Trial
A Study of Comparing Huachansu Plus Thoracic RT Versus RT Alone For ESCC PHASE2 This primary objective of the trial is to study whether the local control o...
Show More Location
Fudan Universtiy Shanghai Cancer Center
Learn More & Join Trial